Kidney adverse events were numerically higher in stage 3 (RR, 1.53; 95% CI, 1.04-2.01), but this association did not reach statistical significance after adjustment for multiple comparisons ( P = .06).
← all excerpts
Intensive Blood Pressure Control and Cardiovascular Outcomes Across Cardiovascular-Kidney-Metabolic Syndrome Stages: A Post Hoc Analysis of the China Rural Hypertension Control Project.
1
0.0600
0.0600